Skip to Main Content

International Flavors & Fragrances Inc.

IFF Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of IFF by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 07, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 29, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Aug 26, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 25, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 25, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jul 01, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jul 01, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 23, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 May 19, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 May 15, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 23, 2025
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Jefferson Shreve House / R Sale $15,001 - $50,000 Apr 07, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 12, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 Oct 14, 2024
Gary C. Peters Senate / D Sale (Full) $15,001 - $50,000 May 14, 2024
Ro Khanna House / D Sale $15,001 - $50,000 Feb 21, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 31, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 02, 2023
Robert J. Wittman House / R Sale $1,001 - $15,000 Sep 15, 2023
Ro Khanna House / D Sale Over $50,000,000 Sep 06, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2023
Lois Frankel House / D Sale $1,001 - $15,000 Aug 09, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 03, 2023
Daniel S. Goldman House / D Sale $1,001 - $15,000 Jul 12, 2023
Gary C. Peters Senate / D Purchase $1,001 - $15,000 Jun 06, 2023
Ro Khanna House / D Sale $1,001 - $15,000 May 23, 2023
Ro Khanna House / D Sale $50,001 - $100,000 May 23, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Apr 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 14, 2023
Daniel S. Goldman House / D Sale $15,001 - $50,000 Mar 06, 2023
Lois Frankel House / D Purchase $1,001 - $15,000 Feb 17, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 14, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Feb 10, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Dec 06, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Nov 02, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 29, 2022
Robert J. Wittman House / R Sale $1,001 - $15,000 Sep 15, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 08, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Sale None Jun 02, 2022
Ro Khanna House / D Sale $1,001 - $15,000 May 10, 2022
Ro Khanna House / D None $1,001 - $15,000 N/A
Alan S. Lowenthal House / D Sale $1,001 - $15,000 Apr 07, 2022
Alan S. Lowenthal House / D Sale $1,001 - $15,000 Apr 06, 2022
IFF Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
IFF Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
IFF Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in IFF holdings by institutional investors

Quarterly net insider trading by IFF's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $10,212 Aug 21, 2002 Issue: Trade (domestic/foreign)

IFF Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

IFF Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
IFF Income Statement
IFF Balance Sheet
IFF Cash Flow
U.S. Patents

New IFF patent grants

  • Patent Title: Cyclohexanols and their use in perfume compositions May. 22, 2018
  • Patent Title: Compositions containing microcapsules coated with deposition proteins May. 22, 2018
  • Patent Title: Aldehyde compounds and their use in perfume compositions Dec. 26, 2017
  • Patent Title: Cyclohexanols and their use in perfume compositions Dec. 05, 2017
  • Patent Title: Stabilized capsule compositions Nov. 14, 2017
  • Patent Title: Organoleptic compounds Nov. 14, 2017
  • Patent Title: Process of preparing 4-methyl-3-decen-5-one Nov. 14, 2017
  • Patent Title: Methods of preparing α,β-unsaturated or α-halo ketones and aldehydes Oct. 24, 2017
  • Patent Title: Hydrogel fragrance capsule, formulations and process for preparing the same Oct. 03, 2017
  • Patent Title: Multi-capsule compositions Sep. 26, 2017
  • Patent Title: Stable, flowable silica capsule formulation Sep. 19, 2017
  • Patent Title: Organoleptic compounds Sep. 12, 2017
  • Patent Title: High-coverage, low oder malodor counteractant compounds and methods of use Aug. 22, 2017
  • Patent Title: 3-(cyclohex-1-en-1-yl)propionates and their use in perfume compositions Aug. 15, 2017
  • Patent Title: Cyclopentanol compounds Jul. 11, 2017
  • Patent Title: Diethyl-methyl-hexahydro-isobenzofurans and their use in perfume compositions Jul. 11, 2017
  • Patent Title: Organoleptic compounds Jul. 11, 2017
  • Patent Title: Polyurea capsules prepared with aliphatic isocyanates and amines Jun. 27, 2017
  • Patent Title: Flavor composition containing flavone glycosides Jun. 20, 2017
  • Patent Title: Cooling enhancing compositions Jun. 13, 2017
  • Patent Title: Flavor-enhancing compounds Jun. 06, 2017
  • Patent Title: Oil-continuous liquid crystalline phase formulation and use of the same May. 23, 2017
  • Patent Title: Organoleptic compounds May. 09, 2017
  • Patent Title: Terpolymer-coated polymer encapsulated active material Apr. 04, 2017
  • Patent Title: Flavor and fragrance compositions containing thiopyran-carbaldehyde Dec. 06, 2016
  • Patent Title: Dimethylcyclohexen-als and their use in perfume compositions Sep. 27, 2016
  • Patent Title: Quinazoline compounds and their use in perfume compositions Aug. 16, 2016
  • Patent Title: Cyclohexanols and their use in perfume compositions Aug. 16, 2016
  • Patent Title: Organoleptic compounds Jul. 26, 2016
  • Patent Title: Cyclopentanol compounds Mar. 22, 2016
  • Patent Title: Organoleptic compounds Mar. 22, 2016
  • Patent Title: Green process for producing 3-methyl-3-pentene-2-one Dec. 22, 2015
  • Patent Title: 3-methyl-benzofuran-5-ol and its use in perfume compositions Dec. 15, 2015
  • Patent Title: Octahydro-benzofurans and their uses in perfume compositions Nov. 10, 2015
  • Patent Title: 2-mercapto-5-methyl-4-heptanone and its use in flavor and fragrance compositions Nov. 10, 2015
  • Patent Title: Peptides imparting umami, salt, dairy and bitter flavor Oct. 27, 2015
  • Patent Title: Low volatile reactive malodor counteractives and methods of use thereof Sep. 08, 2015
  • Patent Title: 3,3-diethyl-alkyl-2-oxa-spiro[4.5]dec-7-enes and their use in perfume compositions Aug. 25, 2015
  • Patent Title: Diethyl-methyl-hexahydro-isobenzofurans and their use in perfume compositions Aug. 25, 2015
  • Patent Title: Quinazoline compounds and their use in perfume compositions Jun. 30, 2015
  • Patent Title: Low volatile reactive malodor counteractives and methods of use thereof Jun. 23, 2015
  • Patent Title: Organoleptic compound Jun. 09, 2015
  • Patent Title: Microcapsules containing active ingredients Jun. 02, 2015
  • Patent Title: 5-sec-butyl-2-(2-4-dimethyl-cyclohex-3-enyl)-5-methyl-[1,3]dioxane and process for making the same May. 12, 2015
  • Patent Title: Pyrimidine derivatives and their use in perfume compositions May. 12, 2015
  • Patent Title: Method for purifying rebaudioside c Nov. 18, 2014
  • Patent Title: 3-methyl-6-cyclohexadecen-1-one and its use in perfume compositions Oct. 14, 2014
  • Patent Title: Organoleptic compound Jul. 22, 2014
  • Patent Title: Organoleptic compound Jul. 08, 2014
  • Patent Title: Quinazoline compounds and their use in perfume compositions Apr. 29, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to IFF from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
IFF News

Recent insights relating to IFF

CNBC Recommendations

Recent picks made for IFF stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IFF

IFF Analyst Ratings

IFF Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
IFF Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $IFF stock a Buy, Sell, or Hold?

  • What is the price target for $IFF stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

IFF Top Shareholders
Shareholder
Shares Held
IFF Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $IFF stock?

  • Who owns the most shares of $IFF stock?

  • What funds own $IFF stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

IFF Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view IFF Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About IFF

International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients.

  • Address New York, NY
  • Market Cap 17.3 billion
  • Employees 22,400
  • Industrial Classification Industrial Organic Chemicals
Back To Top